• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ezetimibe Teva
    / Abic

    Active Ingredient
    Ezetimibe 10mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 ×10mg

    partial basket chart

    Related information


    One tablet of 10 mg  orally , once a day, can be taken at any time with or without food.
    In combination with statins: both medicines can be taken at the same time.


    Primary hypercholesterolemia:
    Ezetimibe Teva administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia.
    Homozygous familial hypercholesterolemia (HoFH):
    Ezetimibe Teva administered with a statin are indicated for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis).
    Homozygous sitosterolemia (Phytosterolemia):
    Ezetimibe Teva is indicated for use in patients with homozygous familial sitosterolemia.


    Hypersensitivity to the active substance or any of its excipients.
    In combination with statins in patients with current hepatic impairment.
    In combination with statins in pregnant of lactating women.

    Important notes

    Contains lactose.

    Teva Pharmaceutical Industries Ltd, Israel